Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia.
Niemann CU, Levin MD, Dubois J, Kersting S, Enggaard L, Veldhuis GJ, Mous R, Mellink CHM, Dobber JA, Poulsen CB, Frederiksen H, Janssens A, Schjødt I, Dompeling EC, Ranti J, Mattsson M, Bellido M, Tran HTT, Nasserinejad K, Kater AP.
Niemann CU, et al. Among authors: kater ap.
Blood. 2021 Feb 25;137(8):1117-1120. doi: 10.1182/blood.2020008608.
Blood. 2021.
PMID: 33027809
Free article.
Clinical Trial.
No abstract available.